Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Defensive Stocks to Buy in a Volatile Market

In this article, we will look at the 10 Best Defensive Stocks to Buy in a Volatile Market.

Investor positioning in defensive stock is at its lowest level it has ever been since 2000. The decline is in stark contrast to the trade policy turmoil and economic uncertainty triggered by the US tariff war. Amid the disparity, Bank of America strategists, led by Michael Hartnett, insist it is high time for investors to become defensive.

Sharing similar sentiments is Trivariate Research founder Adam Parker, who insists investors should look to play defense with equity markets at all-time highs amid heightened volatility. According to Parker, investors should consider purchasing certain dividend stocks to generate passive income.

“We think companies with consistent dividend growth are likely to provide strong defense if there’s a growth scare. We think companies with consistent dividend growth are likely to provide strong defense if there’s a growth scare,” Parker wrote,” Parker wrote.

While the prospects of a bear market are still low, KGI securities warn that there could be a significant earnings decrease in the third quarter. Consequently the research firm insists investors should focus on defensive and high-quality stocks that are less sensitive to economic fluctuations. Consumer defensive stocks stand out because they provide goods and services that consumers cannot live without regardless of the prevailing economic situation.

With that in mind, let’s look at the 10 Best Defensive Stocks to Buy in a Volatile Market.

A portfolio manager analyzing a stock chart, seeking to find the right investments.

Our Methodology

To create our list of the 10 Best Defensive Stocks to Buy in a Volatile Market, we began by screening U.S.-listed companies with market capitalizations exceeding $2 billion, focusing on key defensive sectors such as consumer staples, healthcare, utilities, telecom, real estate, and pharmaceuticals. We then applied three key filters: a beta below 1, consistent EPS growth over the past three years and projected next year, and a dividend yield above 1%. Finally, we identified the most favored stocks among elite hedge funds and ranked them by the number of funds holding positions.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

10. Diageo plc (NYSE:DEO)

Beta as of July 8: 0.28

Dividend Yield as of July 8: 4.10%

Number of Hedge Fund Holders: 39

Diageo PLC (NYSE:DEO) is one of the 10 best defensive stocks to buy in a volatile market. On June 30, the company’s Casamigos brand unveiled its first-ever ready-to-drink (RTD) margarita variety pack. Casamigos Margaritas is the new non-carbonated cocktail made with tequila, natural flavors, and real juice.

Casamigos Margaritas paves the way for Diageo to expand its footprint into the high-growth RTD tequila market. The RTD segment is experiencing double-digit growth as tequila-based options remain in strong demand.

The new brand will expand the company’s premium portfolio, enabling it to capitalize on several converging trends.

“Tequila-based ready-to-drink cocktails are driving the next wave of growth in the category, and consumers are looking for trusted brands that deliver both quality and convenience,” said Jamie Young, VP of Ready to Drink and Ready to Serve at Diageo. “With Casamigos Margaritas, we’re bringing a premium experience into the can—backed by the cultural credibility that set this brand apart.”

Diageo PLC (NYSE:DEO) engages in the production, marketing, and sale of alcoholic beverages. It offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, and Chinese white spirits, among others.

9. The Hershey Company (NYSE:HSY)

Beta as of July 8: 0.28

Dividend Yield as of July 8: 3.30%

Number of Hedge Fund Holders: 40

The Hershey Company (NYSE:HSY) is one of the 10 best defensive stocks to buy in a volatile market. On June 30, the company confirmed it will remove synthetic dyes from all its snacks by the end of 2027. The decision will allow the company to align with directives by US health authorities.

US Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary have already rolled out directives requiring companies to remove synthetic food dyes from the food supply chain. The directive is part of the ministry’s push to address health conditions such as ADHD, obesity, and diabetes.

Some of Hershey’s brands that will be affected by the directive include Dot’s Homestyle Pretzels, SKINNYPOP popcorn, and FULFIL protein bars. Other companies, including Tyson Foods and Conagra Brands, have also started reformulating their brands by removing artificial colors.

The Hershey Company (NYSE:HSY) engages in the manufacture and sale of confectionery products and pantry items.

8. American Electric Power Company, Inc. (NASDAQ:AEP)

Beta as of July 8: 0.41

Dividend Yield as of July 8: 3.59%

Number of Hedge Fund Holders: 55

American Electric Power Company Inc. (NASDAQ:AEP) is one of the 10 best defensive stocks to buy in a volatile market. On June 17, the company named a new general counsel and technology chief, expected to support its long-term strategy.

Rob Berntsen will become executive vice president and general counsel, effective July 14. Berntsen joins American Electric Power Company from Xcel, where he served as executive vice president and chief legal and compliance officer.

On the other hand, Johannes Eckert takes over as the executive vice president and chief information and technology officer, effective July 21. Eckert joins the company, having served as senior vice president and chief information officer at Cox Communications.

The appointment comes as American Electric Power Company Inc. (NASDAQ:AEP) operates the nation’s largest electric transmission system, serving 5.6 million customers. As one of the best defensive stocks, the company generates, transmits, and distributes electricity. It also produces power using various sources, including coal, lignite, natural gas, wind, solar, nuclear, and hydroelectric sources.

7. Duke Energy Corporation (NYSE:DUK)

Beta as of July 8: 0.36

Dividend Yield as of July 8: 3.54%

Number of Hedge Fund Holders: 56

Duke Energy Corporation (NYSE:DUK) is one of the 10 best defensive stocks to buy in a volatile market. On July 1, the company’s subsidiary, Duke Energy Carolinas, filed a request for a 7.7% rate increase in South Carolina. If approved, the new power rates will come into effect early next year.

The proposed rate increase will result in a monthly bill increase of up to $10.38 for residential customers using 1,000 kilowatt-hours of electricity. Commercial customers are to experience a 5.4% average bill increase, while industrial customers will face an average increase of about 5.2%.

The proposed rate increase will increase Duke Energy’s annual revenue in South Carolina by up to $150.5 million. The increase is in response to the investments the company has made in the power grid, improved reliability, and storm resilience.

6. AstraZeneca PLC (NASDAQ:AZN)

Beta as of July 8: 0.17

Dividend Yield as of July 8: 2.22%

Number of Hedge Fund Holders: 56

AstraZeneca PLC (NASDAQ:AZN) is one of the 10 best defensive stocks to buy in a volatile market. On July 4, the company entered into a multi-year agreement with Modella AI. The two are joining forces to accelerate AI-driven clinical development in oncology.

As part of the strategic partnership, AstraZeneca is to gain access to Modella AI’s multi-modal foundation models. The models feature rich data extraction from various types of data to accelerate the clinical development of the oncology portfolio.

“Through the use of foundation models, combined with our unique datasets and AI expertise, we are confident in our strategy to accelerate development and increase the probabilities of success in our oncology clinical trials,” AstraZeneca oncology research and development (R&D) chief AI and data scientist Jorge Reis-Filho stated.

AstraZeneca plans to leverage AI models for cancer research and development capabilities to enhance discovery and clinical development.

AstraZeneca PLC (NASDAQ:AZN) is a science-led biopharmaceutical company that focuses on the research, development, and commercialization of prescription medicines. It develops medicines for diseases in the areas of oncology, cardiovascular, renal, metabolism, respiratory, immunology, and rare diseases.

5. Novo Nordisk A/S (NYSE:NVO)

Beta as of July 8: 0.22

Dividend Yield as of July 8: 2.34%

Number of Hedge Fund Holders: 60

Novo Nordisk A/S (NYSE:NVO) is one of the 10 best defensive stocks to buy in a volatile market. On July 7, the company received a significant boost in its proposed $2.34 billion investment in a factory in Rome, Italy.

Italian authorities have already appointed Francesco Rocca as president of the Lazio region, which includes Rome. He is responsible for accelerating projects related to the Novo Nordisk facility. The Lazio region has already approved upgrades for road links worth more than €2.9 million.

The proposed facility is designed to produce weight loss and diabetes medications, with production scheduled to commence in late 2026 or early 2027. The Italian government has already given Novo Nordisk the green light to upgrade the capacity of its Anagni site.

4. Abbott Laboratories (NYSE:ABT)

Beta as of July 8: 0.74

Dividend Yield as of July 8: 1.74%

Number of Hedge Fund Holders: 70

Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at Oppenheimer reiterated an ‘Outperform’ rating on the stock and a $14 price target. The bullish stance follows the Centers for Medicare & Medicaid Services (CMS) final decision on transcatheter edge-to-edge repair for the tricuspid valve (T-TEER).

The latest decision includes the elimination of the requirement for an electrophysiologist and multi-modality imaging specialists. Additionally, it eliminates the need for patient consultation with all team members. The reduction in the requirement is a significant boost for tricuspid valve (T-TEER) as it shares similarities with Edwards Lifesciences’ transcatheter tricuspid valve replacement (TTVR).

Despite conflicting stakeholder opinions regarding volume standards, CMS chose not to enforce volume or resource requirements. Instead, it retained flexible definitions of optimal medical therapy in line with FDA labeling without specifying the requirements for tricuspid regurgitation severity.

Abbott Laboratories (NYSE:ABT) is a healthcare company that discovers, develops, manufactures, and sells a range of healthcare products. It is one of the best defensive stocks, as it provides generic pharmaceuticals, laboratory, and transfusion medicine systems.

3. T-Mobile US Inc. (NASDAQ:TMUS)

Beta as of July 8: 0.63

Dividend Yield as of July 8: 1.48

Number of Hedge Fund Holders: 75

T-Mobile US Inc. (NASDAQ:TMUS) is one of the 10 best defensive stocks to buy in a volatile market. On July 7, BofA securities reinstated coverage of the stock with a ‘Neutral’ rating and a $255 price target. The Neutral stance comes amid concerns about the stock’s premium valuation as it trades at a price-to-earnings multiple of 23.

In addition, BofA remains wary about the company’s high institutional ownership and record-high growth forecasts, which hint at limited upside potential. Nevertheless, the research firm has affirmed T-Mobile’s industry leadership in postpaid phone net ads amid revenue and EBITDA growth.

The communication services company is also in a solid financial position with $31.6 billion in EBITDA and 5.3% revenue growth over the last 12 months. BofA believes T Mobile is in a position to follow other cable companies with more competitive pricing and promotional offers to strengthen its edge in the industry.

2. Comcast Corporation (NASDAQ:CMCSA)

Beta as of July 8: 0.95

Dividend Yield as of July 8: 3.70%

Number of Hedge Fund Holders: 81

Comcast Corporation (NASDAQ:CMCSA) is one of the 10 best defensive stocks to buy in a volatile market. On July 7, Citi analysts said U.S. tax reforms—including full bonus depreciation and expanded interest expense deductions—are set to boost cash flows for North American telecom operators. These changes, part of a new fiscal bill signed by President Trump, are expected to lift industry-wide free cash flow by 10% in 2025 and improve long-term profitability.

Citi reiterated its “Buy” rating on Comcast, citing improved cash flow prospects and potential for accelerated buybacks. Alongside Verizon and AT&T, Comcast is expected to be a key beneficiary of the legislation, which also includes new spectrum access initiatives for the telecom sector.

1. Merck & Co., Inc. (NYSE:MRK)

Beta as of July 8: 0.40

Dividend Yield as of July 8: 4.09%

Number of Hedge Fund Holders: 93

Merck & Co., Inc. (NYSE:MRK) is one of the 10 best defensive stocks to buy in a volatile market. On July 2, UBS reiterated a ‘Buy’ rating on the stock and a $105 price target. According to analyst Trung Huynh, the company’s human papillomavirus (HPV) vaccine, Gardasil, is a key driver of growth.

Huynh insists investors have only shown limited near-term interest in the stock ahead of key inflection points. For starters, the return of Gardasil shipments to China is expected to bolster the company’s revenue base. According to the investment firm Gardasil, inventory levels in China remain elevated owing to expanded promotional efforts spanning five regions.

Following $200 million in shipments into China, UBS does not expect additional shipments. However, it expects Merck to generate up to $5.8 billion in Gardasil sales. Additionally, Huynh is optimistic about the full Phase 3 oral PCSK9 CORALreef Lipids readout in hypercholesterolemia.

Merck & Co., Inc. (NYSE:MRK) develops and provides solutions in areas like biopharmaceutical therapies, scientific research tools, and materials for electronics, including smartphones and televisions.

While we acknowledge the potential of MRK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 Materials Stocks to Buy According to Analysts and 10 Best Organic Food and Farming Stocks to Buy Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.